No bio added yet
No link added
Sleep Cycle's Revenue Set to Rise 10% with Strong Revenue Model
Update Q1 2025 (updated 250510) The latest user‐growth data suggest headwinds for top-line revenue, but management’s active repricing initiatives should help offset this. By combining modest user gains with targeted price increases, the company can still drive overall revenue growth.Read more
Stable Margins, Strong Pricing Power - a Mean Reversion Opportunity in Huhtamäki?
Q1 2025 Update Decent revenue and earnings report, numbers supporting a mean reversion play on multiple. Catalysts Strong Pricing Power: Consistent improvement in gross margins, rising from mid-15% levels in early years to nearly 19% in recent projections.Read more
HEXPOL AB: Sustained Long Term Growth, Stable Margins, and Strategic M&A
Catalysts Historic Growth: HEXPOL has demonstrated robust growth over the years—expanding from modest beginnings in 2001 to achieving sales over 22 billion SEK in 2023—and its strong track record suggests that this momentum is likely to continue. Gross Margins: The company has maintained stable gross margins (18-23%) last five years, reflecting enduring pricing power vs customers.Read more
I-Tech's Selektope Expansion Will Drive 28% Revenue Increase in 5 Years
Q1 2025 Update Updates to the model and supporting figures below Solid report, above expectation on all lines. Good cashflows, removing doubts/concerns about this topic.Read more
Qt Group Oyj’s somewhat overvalued, but with a potential for extra dividends
Catalysts Structural market tailwinds – The demand for embedded‑device software and graphical user interfaces continues to grow. Qt’s tools help companies meet the exponential growth of the embedded‑device market and the rapidly increasing speed of software‑development life cycles.Read more
Cadeler set to grow with market.
Catalysts Structural market tailwinds: Offshore wind installations are projected to grow from approximately 8 GW in 2024 to 34 GW by 2030 (28% CAGR), supported by strong policy initiatives in the EU, U.S., and China targeting over 400 GW of capacity. Source.Read more
EQL Pharma's management aiming for 30% Revenue Growth in 5 Years
2025 Q1 update Strong revenue growth yoy 45% exceding expectations. Strong EPS of 178%, however easy comps should be noted.Read more
AutoStore: A Warehouse Automation Leader with 20% Upside Potential - if growth comes.
Q1 2025 Update Very weak quarter both in terms of order intake 142 mUSD (also including about 30 mUSD for "as a service" orders) vs 182 last Q!, no implications for long term valuation. No need to rush in to this stock.Read more
Nederman: Cautiously Overvalued Amid Modest Growth and Margin uncertainties
Catalysts Industry Tailwinds : Nederman is poised to benefit from increasing global awareness and regulatory demands for improved air quality. Industries are investing in advanced air filtration systems to enhance employee health and reduce heating costs by maintaining cleaner air environments.Read more